bf/NASDAQ:HUMA_icon.jpeg

NASDAQ:HUMAW

Humacyte, Inc.

  • Stock

USD

Last Close

1.31

06/11 22:31

Market Cap

681.16M

Beta: -

Volume Today

1.30M

Avg: -

PE Ratio

−3.64

PFCF: −4.65

    Description

    Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigation...Show More

    Earnings

    Earnings per Share (Estimate*)

    0.0020.0040.0060.0080.012022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    Revenue (Estimate*)

    0.000.000.010.010.012022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    *Estimate based on analyst consensus